Insulet Secures FDA 510(k) Clearance For The Omnipod 5 App For iPhone
Portfolio Pulse from Benzinga Newsdesk
Insulet has secured FDA 510(k) clearance for the Omnipod 5 app for iPhone. The Omnipod 5 Automated Insulin Delivery System, which had its full commercial launch in August 2022 in the U.S., previously offered smartphone control for customers using compatible Android devices. The new clearance will allow the system to be controlled from a compatible iPhone.
October 23, 2023 | 10:04 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Insulet's FDA clearance for the Omnipod 5 app for iPhone could potentially increase the user base of the Omnipod 5 system, as it now caters to both Android and iPhone users. This could have a positive impact on the company's revenues.
The FDA clearance for the Omnipod 5 app for iPhone expands the potential user base of the Omnipod 5 system to include iPhone users. This could lead to increased sales and revenues for Insulet, which could positively impact the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100